{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:10:28Z","timestamp":1767183028628,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006692","name":"Universit\u00e0 degli Studi di Torino","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006692","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Postoperative assessment of acromegaly activity is typically performed at least 3\u00a0months after neurosurgery (NS). Few studies have evaluated the use of early postoperative growth hormone (GH) levels as a test to predict short- and long-term remission of acromegaly. Our objective was to evaluate the diagnostic performance of serum random GH on a postoperative day one (D1-rGH) and two (D2-rGH), particularly in predicting long-term disease persistence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>Forty-one subjects with acromegaly who were undergoing NS were enrolled (mean age\u2009\u00b1\u2009SD 47.4\u2009\u00b1\u200913.1\u00a0years at diagnosis; women 54%; macroadenomas 71%). The final assessment of disease activity was performed one year after NS. ROC curves were used to evaluate the diagnostic performance of D1-rGH and D2-rGH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After a 1-year follow-up, the overall remission rate was 55%. ROC analysis identified an optimal D1-rGH cut-off value of 2.1\u00a0ng\/mL for diagnosing long-term disease persistence (55.6% SE; 90.9% SP). The cut-off point became 2.5\u00a0ng\/mL after maximizing specificity for disease persistence (yielding a 100% positive predictive value) and 0.3\u00a0ng\/mL after maximizing sensitivity for disease remission. The optimal D2-rGH cut-off value was 0.6\u00a0ng\/mL (81.8% SE; 50% SP); the cut-off point became 2.9\u00a0ng\/mL after maximizing specificity and 0.1\u00a0ng\/mL after maximizing sensitivity, with no clinical utility.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>D1-rGH could be a highly specific test for the early diagnosis of long-term acromegaly persistence, which is predicted by a value\u2009&gt;\u20092.5\u00a0ng\/mL with a great degree of certainty. The diagnostic performance of D2-rGH was insufficient. Further research is required to validate these preliminary results prior to modifying the postoperative management of acromegaly.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-021-01553-0","type":"journal-article","created":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T15:03:32Z","timestamp":1618067012000},"page":"2427-2433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8169-8145","authenticated-orcid":false,"given":"V.","family":"Cambria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Beccuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Prencipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Penner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Romanisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Zenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Grottoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,10]]},"reference":[{"issue":"6","key":"1553_CR1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1046\/j.1365-2796.2000.00667.x","volume":"247","author":"S Valdemarsson","year":"2000","unstructured":"Valdemarsson S, Ljunggren S, Bramnert M, Norrhamn O, Nordstr\u00f6m CH (2000) Early postoperative growth hormone levels: high predictive value for long-term outcome after surgery for acromegaly. J Intern Med 247(6):640\u2013650. https:\/\/doi.org\/10.1046\/j.1365-2796.2000.00667.x","journal-title":"J Intern Med"},{"issue":"11","key":"1553_CR2","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951. https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1553_CR3","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1210\/jc.2011-0554","volume":"96","author":"JA Jane","year":"2011","unstructured":"Jane JA, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO et al (2011) Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab 96(9):2732\u20132740. https:\/\/doi.org\/10.1210\/jc.2011-0554","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1553_CR4","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1210\/jc.2013-1036","volume":"98","author":"RM Starke","year":"2013","unstructured":"Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA (2013) Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metab 98(8):3190\u20133198. https:\/\/doi.org\/10.1210\/jc.2013-1036","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1553_CR5","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1210\/jc.2009-2670","volume":"95","author":"A Giustina","year":"2010","unstructured":"Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF et al (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141\u20133148. https:\/\/doi.org\/10.1210\/jc.2009-2670","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 4","key":"1553_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/ep.17.s4.1","volume":"17","author":"L Katznelson","year":"2011","unstructured":"Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK et al (2011) American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly\u20132011 update. Endocr Pract 17(Suppl 4):1\u201344. https:\/\/doi.org\/10.4158\/ep.17.s4.1","journal-title":"Endocr Pract"},{"key":"1553_CR7","doi-asserted-by":"publisher","unstructured":"Kim EH, Oh MC, Lee EJ, Kim SH. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly. Neurosurgery. 2012;70(5):1106\u201313; discussion 13. doi: https:\/\/doi.org\/10.1227\/NEU.0b013e31823f5c16","DOI":"10.1227\/NEU.0b013e31823f5c16"},{"issue":"11","key":"1553_CR8","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1507\/endocrj.EJ17-0261","volume":"64","author":"H Nishioka","year":"2017","unstructured":"Nishioka H, Fukuhara N, Yamaguchi-Okada M, Takeshita A, Takeuchi Y, Yamada S (2017) Pitfalls in early biochemical evaluation after transsphenoidal surgery in patients with acromegaly. Endocr J 64(11):1073\u20131078. https:\/\/doi.org\/10.1507\/endocrj.EJ17-0261","journal-title":"Endocr J"},{"key":"1553_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ghir.2018.03.002","volume":"41","author":"R Rotermund","year":"2018","unstructured":"Rotermund R, Burkhardt T, Rohani Z, Jung R, Aberle J, Flitsch J (2018) Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly. Growth Horm IGF Res 41:64\u201370. https:\/\/doi.org\/10.1016\/j.ghir.2018.03.002","journal-title":"Growth Horm IGF Res"},{"key":"1553_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.wneu.2018.11.069","volume":"122","author":"F Penner","year":"2019","unstructured":"Penner F, Prencipe N, Pennacchietti V, Pacca P, Cambria V, Garbossa D et al (2019) Super giant growth hormone-secreting pituitary adenoma in young woman: from ventricles to nose. World Neurosurg 122:544\u2013548. https:\/\/doi.org\/10.1016\/j.wneu.2018.11.069","journal-title":"World Neurosurg"},{"issue":"5","key":"1553_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/BF03346389","volume":"31","author":"G Aimaretti","year":"2008","unstructured":"Aimaretti G, Boschetti M, Corneli G, Gasco V, Valle D, Borsotti M et al (2008) Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population. J Endocrinol Invest 31(5):445\u2013449. https:\/\/doi.org\/10.1007\/BF03346389","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1553_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","volume":"20","author":"A Lavrentaki","year":"2017","unstructured":"Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N (2017) Epidemiology of acromegaly: review of population studies. Pituitary 20(1):4\u20139. https:\/\/doi.org\/10.1007\/s11102-016-0754-x","journal-title":"Pituitary"},{"issue":"3\u20134","key":"1553_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/bf01815441","volume":"8","author":"DK L\u00fcdecke","year":"1985","unstructured":"L\u00fcdecke DK (1985) Recent developments in the treatment of acromegaly. Neurosurg Rev 8(3\u20134):167\u2013173. https:\/\/doi.org\/10.1007\/bf01815441","journal-title":"Neurosurg Rev"},{"issue":"3\u20134","key":"1553_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000095533","volume":"83","author":"DK Ludecke","year":"2006","unstructured":"Ludecke DK, Abe T (2006) Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1000 operations. Neuroendocrinology 83(3\u20134):230\u2013239. https:\/\/doi.org\/10.1159\/000095533","journal-title":"Neuroendocrinology"},{"issue":"5","key":"1553_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1507\/endocrj.50.635","volume":"50","author":"M Kurosaki","year":"2003","unstructured":"Kurosaki M, Luedecke DK, Abe T (2003) Effectiveness of secondary transnasal surgery in GH-secreting pituitary macroadenomas. Endocr J 50(5):635\u2013642. https:\/\/doi.org\/10.1507\/endocrj.50.635","journal-title":"Endocr J"},{"issue":"3","key":"1553_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1365-2265.1996.8080817.x","volume":"45","author":"S Yamada","year":"1996","unstructured":"Yamada S, Aiba T, Takada K, Ozawa Y, Shimizu T, Sawano S et al (1996) Retrospective analysis of long-term surgical results in acromegaly: preoperative and postoperative factors predicting outcome. Clin Endocrinol (Oxf) 45(3):291\u2013298. https:\/\/doi.org\/10.1046\/j.1365-2265.1996.8080817.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1553_CR17","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3171\/jns.2002.97.6.1282","volume":"97","author":"RA Kristof","year":"2002","unstructured":"Kristof RA, Neuloh G, Redel L, Klingm\u00fcller D, Schramm J (2002) Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission. J Neurosurg 97(6):1282\u20131286. https:\/\/doi.org\/10.3171\/jns.2002.97.6.1282","journal-title":"J Neurosurg"},{"issue":"12","key":"1553_CR18","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1210\/jc.2005-0901","volume":"90","author":"RA Feelders","year":"2005","unstructured":"Feelders RA, Bidlingmaier M, Strasburger CJ, Janssen JA, Uitterlinden P, Hofland LJ et al (2005) Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels. J Clin Endocrinol Metab 90(12):6480\u20136489. https:\/\/doi.org\/10.1210\/jc.2005-0901","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1553_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1046\/j.1365-2265.2003.01900.x","volume":"60","author":"JA Takahashi","year":"2004","unstructured":"Takahashi JA, Shimatsu A, Nakao K, Hashimoto N (2004) Early postoperative indicators of late outcome in acromegalic patients. Clin Endocrinol (Oxf) 60(3):366\u2013374. https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01900.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1553_CR20","doi-asserted-by":"publisher","unstructured":"Sarkar S, Jacob KS, Pratheesh R, Chacko AG. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays. Acta Neurochir (Wien). 2014;156(7):1379\u201387; discussion 87. doi: https:\/\/doi.org\/10.1007\/s00701-014-2098-5","DOI":"10.1007\/s00701-014-2098-5"},{"issue":"4","key":"1553_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3171\/jns.2003.98.4.0719","volume":"98","author":"MD Krieger","year":"2003","unstructured":"Krieger MD, Couldwell WT, Weiss MH (2003) Assessment of long-term remission of acromegaly following surgery. J Neurosurg 98(4):719\u2013724. https:\/\/doi.org\/10.3171\/jns.2003.98.4.0719","journal-title":"J Neurosurg"},{"issue":"2","key":"1553_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4103\/0028-3886.177622","volume":"64","author":"P Dutta","year":"2016","unstructured":"Dutta P, Korbonits M, Sachdeva N, Gupta P, Srinivasan A, Devgun JS et al (2016) Can immediate postoperative random growth hormone levels predict long-term cure in patients with acromegaly? Neurol India 64(2):252\u2013258. https:\/\/doi.org\/10.4103\/0028-3886.177622","journal-title":"Neurol India"},{"issue":"3","key":"1553_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12020-018-1590-8","volume":"60","author":"X Antunes","year":"2018","unstructured":"Antunes X, Ventura N, Camilo GB, Wildemberg LE, Guasti A, Pereira PJM et al (2018) Predictors of surgical outcome and early criteria of remission in acromegaly. Endocrine 60(3):415\u2013422. https:\/\/doi.org\/10.1007\/s12020-018-1590-8","journal-title":"Endocrine"},{"key":"1553_CR24","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.1016\/j.wneu.2018.11.186","volume":"123","author":"D Solari","year":"2019","unstructured":"Solari D, Zenga F, Angileri FF, Barbanera A, Berlucchi S, Bernucci C et al (2019) A survey on pituitary surgery in Italy. World Neurosurg 123:e440\u2013e449. https:\/\/doi.org\/10.1016\/j.wneu.2018.11.186","journal-title":"World Neurosurg"},{"issue":"1","key":"1553_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11102-020-01086-4","volume":"24","author":"N Qiao","year":"2021","unstructured":"Qiao N, Shen M, He W, He M, Zhang Z, Ye H et al (2021) Machine learning in predicting early remission in patients after surgical treatment of acromegaly: a multicenter study. Pituitary 24(1):53\u201361. https:\/\/doi.org\/10.1007\/s11102-020-01086-4","journal-title":"Pituitary"},{"issue":"2","key":"1553_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12020-019-02121-6","volume":"67","author":"Y Fan","year":"2020","unstructured":"Fan Y, Li Y, Feng S, Bao X, Feng M, Wang R (2020) Development and assessment of machine learning algorithms for predicting remission after transsphenoidal surgery among patients with acromegaly. Endocrine 67(2):412\u2013422. https:\/\/doi.org\/10.1007\/s12020-019-02121-6","journal-title":"Endocrine"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01553-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-021-01553-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01553-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T14:55:03Z","timestamp":1633877703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-021-01553-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,10]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1007\/s40618-021-01553-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2021,4,10]]},"assertion":[{"value":"29 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local Ethical Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}